Coenzyme-A Inc.
PPII · Other OTC · USD
0,0002USD
0,00 (0,00 %)Stand 9. Nov., 21:00
Kennzahlen
- Eröffnung
- 0,0002
- Vortag
- 0,0002
- Tagesspanne
- 0,0002 – 0,0002
- 52 Wochen
- 0,0002 – 0,0002
- Volumen
- 191
- Ø Volumen
- 176
- Börsenwert
- 111 $
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 1,8
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Gewinn je Aktie · Erwartet |
|---|
| Gewinn je Aktie · Tatsächlich |
| Abweichung |
| Umsatz · Tatsächlich |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
- 6. Feb. 20121:500
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
AOBIAmerican Oriental Bioengineering, Inc.0,0130,00 %
APYIAspyra Inc.0,00020,00 %
BRSFBrain Scientific Inc.0,00060,00 %
CLVRClever Leaves Holdings Inc.0,0010,00 %
CRFTFBC Craft Supply Co. Ltd.0,000,00 %
ENCWEnchanted World Inc.0,00030,00 %
HLTHQCue Health Inc.0,00010,00 %
HTGMQHTG Molecular Diagnostics, Inc.0,00010,00 %
Über das Unternehmen
Coenzyme-A Inc. specializes in the development and manufacturing of nutraceutical supplements, alongside a comprehensive range of skincare and haircare products, which it distributes across the United States and internationally. Its extensive product portfolio includes vitality-boosting beverages and rejuvenating facial serums. The company also formulates solutions for weight management, various dermatological concerns, and the support of healthy fatty acid and cholesterol metabolism. Additionally, Coenzyme-A Inc. offers nutritional blends specifically designed to bolster bone, joint, ligament, cartilage, and connective tissue functions. Further expanding its offerings, the firm provides tailored supplements for sports performance, distinct formulas for women and men, and products focused on general wellness, energy enhancement, and body sculpting. Coenzyme-A Inc. was established in 1998 and is headquartered in Lynnwood, Washington.
Führung
- Nickoloaus D. SkourasChief Executive Officer & President
- CEO
- Nickoloaus D. Skouras
- Mitarbeitende
- 0
- Hauptsitz
- Lynnwood, WA, US
- Sektor
- Healthcare
- Branche
- Drug Manufacturers - Specialty & Generic
- Börsengang
- 8. Sept. 2009
- Website
- coenzymea.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.